Evaluation of safety and efficacy of parental Fish oil for intestinal failure associated liver disease

Evaluation of safety and efficacy of parental Fish oil for intestinal failure associated liver disease - Evaluation of safety and efficacy of parental Fish oil for intestinal failure associated liver disease

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025294

Enrollment

Registered

2016-12-15

Start date

2016-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intestinal failure associated liver disease parental nutrition associated cholestasis

Interventions

parenteral administration of parental fish oil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. infants who admitted to our NICU 2. infants at risk of Intestinal failure associated liver disease and parenteral nutrition associated cholestasis 3. infants with Intestinal failure associated liver disease and parenteral nutrition associated cholestasis

Exclusion criteria

Exclusion criteria: 1. Refusal of informed consent

Design outcomes

Primary

Measure	Time frame
improvement of liver function test	—

Secondary

Measure	Time frame
mortality withdrawal from parental nutrition physical growth needs of liver transplantation	—

Countries

Japan

Contacts

Public ContactSumie Fujinuma

Saitama Medical Center, Saitama Medical University Department of Pediatrics

sahrau1112@hotmail.com+81-49-228-3725

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026